Jefferies Downgrades Instil Bio to Hold, Raises Price Target to $11
Portfolio Pulse from Benzinga Newsdesk
Jefferies analyst Kelly Shi downgraded Instil Bio (NASDAQ:TIL) from Buy to Hold while raising the price target from $5 to $11.

April 12, 2024 | 1:24 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Instil Bio was downgraded by Jefferies from Buy to Hold, but the price target was increased from $5 to $11.
The downgrade to Hold suggests a neutral outlook on the stock's immediate growth potential, indicating that the stock might not outperform the market in the short term. However, the increase in the price target from $5 to $11 reflects a positive revision of the company's valuation, suggesting underlying strengths or potential that could support the stock price in the future. The mixed nature of this update (downgrade with a higher price target) could lead to varied interpretations by investors, potentially causing short-term price volatility as the market digests the news.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100